Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Health Catalyst (HCAT) Current Deferred Tax Assets (2018 - 2020)

Historic Current Deferred Tax Assets for Health Catalyst (HCAT) over the last 3 years, with Q2 2020 value amounting to $455000.0.

  • Health Catalyst's Current Deferred Tax Assets fell 4615.38% to $455000.0 in Q2 2020 from the same period last year, while for Jun 2020 it was $455000.0, marking a year-over-year decrease of 4615.38%. This contributed to the annual value of $937000.0 for FY2019, which is 4437.6% up from last year.
  • Per Health Catalyst's latest filing, its Current Deferred Tax Assets stood at $455000.0 for Q2 2020, which was down 4615.38% from $493000.0 recorded in Q1 2020.
  • Over the past 5 years, Health Catalyst's Current Deferred Tax Assets peaked at $978000.0 during Q3 2019, and registered a low of $455000.0 during Q2 2020.
  • Its 3-year average for Current Deferred Tax Assets is $726166.7, with a median of $747000.0 in 2018.
  • Per our database at Business Quant, Health Catalyst's Current Deferred Tax Assets surged by 4437.6% in 2019 and then crashed by 4615.38% in 2020.
  • Quarter analysis of 3 years shows Health Catalyst's Current Deferred Tax Assets stood at $649000.0 in 2018, then soared by 44.38% to $937000.0 in 2019, then plummeted by 51.44% to $455000.0 in 2020.
  • Its Current Deferred Tax Assets stands at $455000.0 for Q2 2020, versus $493000.0 for Q1 2020 and $937000.0 for Q4 2019.